Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity

Lung Cancer

Volumn 41, Issue 1, 2003, Pages 91-99

  Sy, Shirley M H ^a   Wong, Nathalie ^a   Mok, Tony S K ^a   Tsao, Ming Sound ^b   Lee, Tak Wai ^a   Tse, Gary ^a   Blackhall, Fiona H ^b   Johnson, Philip J ^a   Yim, Anthony P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Comparative genomic hybridization; Ethnicity; Gender; Lung adenocarcinoma; Smoking

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; ETHNOLOGY; FEMALE; HUMAN; HUMAN GENOME; LUNG ADENOCARCINOMA; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

EID: 0038479962     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00138-7     Document Type: Article

References (41)

1. Wynder E.L., Goodman M.T., Hoffmann D. Lung cancer etiology: challenges of the future. Carcinog. Compr. Surv. 8:1985;39-62.
2. Thun M.J., Lally C.A., Flannery J.T., Calle E.E., Flanders W.D., Heath C.W. Cigarette smoking and changes in the histopathology of lung cancer. J. Natl. Cancer Inst. 89:(21):1997;1580-1586.
3. Brownson R.C., Loy T.S., Ingram E., Myers J.L., Alavanja M.C., Sharp D.J., Chang J.C. Lung cancer in nonsmoking women. Histology and survival patterns. Cancer. 75:(1):1995;29-33.
4. Koo L.C., Ho J.H., Lee N. An analysis of some risk factors for lung cancer in Hong Kong. Int. J. Cancer. 35:(2):1985;149-155.
5. Lam K.Y., Fu K.H., Wong M.P., Wang E.P. Significant changes in the distribution of histologic types of lung cancer in Hong Kong. Pathology. 25:(2):1993;103-105.
6. Lam W.K., So S.Y., Yu D.Y. Clinical features of bronchogenic carcinoma in Hong Kong. Review of 480 patients. Cancer. 52:(2):1983;369-376.
7. Koo L.C., Ho J.H. Worldwide epidemiological patterns of lung cancer in nonsmokers. Int. J. Epidemiol. 19:(Suppl. 1):1990;S14-S23.
8. Gao Y.T., Blot W.J., Zheng W., Ershow A.G., Hsu C.W., Levin L.I., Zhang R., Fraumeni J.F., Jr. Lung cancer among Chinese women. Int. J. Cancer. 40:(5):1987;604-609.
9. Wang T.-J., Zhou B.-S. Meta-analysis of the potential relationship between exposure to environmental tobacco smoke and lung cancer in nonsmoking Chinese women. Lung Cancer. 16:(2-3):1997;145-150.
10. Alberg A.J., Samet J.M. Epidemiology of lung cancer. Chest. 123:(Suppl. 1):2003;21S-49S.
11. Sanchez-Cespedes M., Ahrendt S.A., Piantadosi S., Rosell R., Monzo M., Wu L., Westa W.H., Yang S.C., Jen J., Sidransky D. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res. 61:(4):2001;1309-1313.
12. Luk C., Tsao M.-S., Bayani J., Shepherd F., Jeremy A. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet. Cytogenet. 125:(2):2001;87-99.
13. Bjorkqvist A.M., Tammilehto L., Nordling S., Nurminen M., Anttila S., Mattson K., Knuutila S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br. J. Cancer. 77:(2):1998;260-269.
14. Pei J., Balsara B.R., Li W., Litwin S., Gabrielson E., Feder M., Jen J., Testa J.R. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer. 31:(3):2001;282-287.
15. Ahrendt S.A., Chow J.T., Yang S.C., Wu L., Zhang M.J., Jen J., Sidransky D. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res. 60:(12):2000;3155-3159.
16. Gao H.G., Chen J.K., Stewart J., Song B., Rayappa C., Whong W.Z., Ong T. Distribution of p53 and K-ras mutations in human lung cancer tissues. Carcinogenesis. 18:(3):1997;473-478.
17. Takagi Y., Koo L.C., Osada H., Ueda R., Kyaw K., Ma C.C., Suyama M., Saji S., Takahashi T., Tominaga S., et al. Distinct mutational spectrum of the p53 gene in lung cancers from Chinese women in Hong Kong. Cancer Res. 55:(22):1995;5354-5357.
18. Salgia R., Skarin A.T. Molecular abnormalities in lung cancer. J. Clin. Oncol. 16:(3):1998;1207-1217.
19. Wang Y.C., Lee H.S., Chen S.K., Yang S.C., Chen C.Y. Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome. J. Cancer Res. Clin. Oncol. 124:(9):1998;517-522.
20. Lung M.L., Wong M., Lam W.K., Lau K.S., Kwan S., Fu K.H., Cheung H., Yew W.W. Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer. 70:(4):1992;760-763.
21. Kallioniemi A., Kallionemi O-P, Sudar D., Rudovitz D., Gray J.W., Waldman F., Pinkle D. Comparavtive genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
22. Wong N., Lai P., Lee S.W., Fan S., Pang E., Liew C.T., Sheng Z., Lau J.W.Y., Johnson P.J. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis. Am J Pathol. 154:1999;37-43.
23. du Manoir S., Schrock E., Bentz M., Speicher M.R., Joos S., Ried T., Lichter P., Cremer T. Quantitative analysis of comparative genomic hybridization. Cytometry. 19:(1):1995;27-41.
24. du Manoir S., Kallioniemi O.P., Lichter P., Piper J., Benedetti P.A., Carothers A.D., Fantes J.A., Garcia-Sagredo J.M., Gerdes T., Giollant M., et al. Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry. 19:(1):1995;4-9.
25. Wu X., Zhao H., Amos C.I., Shete S., Makan N., Hong W.K., Kadlubar F.F., Spitz M.R. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J. Natl. Cancer Inst. 94:(9):2002;681-690.
26. Fan R., Wu M.T., Miller D., Wain J.C., Kelsey K.T., Wiencke J.K., Christiani D.C. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol. Biomark. Prev. 9:(10):2000;1037-1042.
27. Wang Y.C., Chen C.Y., Chen S.K., Chang Y.Y., Lin P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin. Cancer Res. 5:(1):1999;129-134.
28. Bennett W.P., Alavanja M.C.R., Blomeke B., Vahakangas K.H., Castren K., Welsh J.A., Bowman E.D., Khan M.A., Flieder D.B., Harris C.C. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J. Natl. Cancer Inst. 91:(23):1999;2009-2014.
29. Sozzi G., Sard L., De Gregorio L., Marchetti A., Musso K., Buttitta F., Tornielli S., Pellegrini S., Veronese M.L., Manenti G., Incarbone M., Chella A., Angeletti C.A., Pastorino U., Huebner K., Bevilaqua G., Pilotti S., Croce C.M., Pierotti M.A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res. 57:(11):1997;2121-2123.
30. Hemminki K., Koskinen M., Rajaniemi H., Zhao C. DNA adducts, mutations, and cancer. Regulat Toxicol Pharmacol. 32:(3):2000;264-275.
31. Koskinen M., Vodickova M., Rajaniemi H., Warner S.C., Hemminki K. Kinetics of formation of specific styrene oxide adducts in double-stranded DNA. Chem. Biol. Interact. 138:(2):2001;111-124.
32. Cosman M., Hingerty B.E., Geacintov N.E., Broyde S., Patel D.J. Structural Alignments of (+)- and (()-trans-anti-benzo[a]pyrene-DG adducts positioned at a DNA template-primer junction. Biochemistry. 34:(46):1995;15334-15350.
33. Paakko P., Nuorva K., Kamel D., Soini Y. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. Am. J. Respir. Cell Mol. Biol. 7:(3):1992;325-334.
34. Kern J.A., Slebos R.J.C., Top B., Rodenhuis S., Lager D., Robinson R.A., Weiner D., Schwartz D.A. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest. 93:(2):1994;516-520.
35. Noguchi M., Murakami M., Bennett W., Lupu R., Hui F., Jr, Harris C.C., Gerwin B.I. Biological consequences of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells. Cancer Res. 53:(9):1993;2035-2043.
36. Marty L., Taviaux S., Fort P. Expression and human chromosomal localization to 17q25 of the growth-regulated gene encoding the mitochondrial ribosomal protein MRPL12. Genomics. 41:(3):1997;453-457.
37. Marty L., Fort P. A delayed-early response nuclear gene encoding MRPL12, the mitochondrial homologue to the bacterial translational regulator L7/L12 protein. J. Biol. Chem. 271:(19):1996;11468-11476.
38. Mukhopadhyay A., Ni J., Zhai Y., Yu G.-L., Aggarwal B.B. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappa B, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274:(23):1999;15978-15981.
39. Field J.K., Neville E.M., Stewart M.P., Swift A., Liloglou T., Risk J.M., Ross H., Gosney J.R., Donnelly R.J. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer. Br. J. Cancer. 74:(12):1996;1968-1974.
40. Kanamoto T., Hellman U., Heldin C.H., Souchelnytskyi S. Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair. EMBO J. 21:(5):2002;1219-1230.
41. Lakari E., Pylkas P., Pietarinen-Runtti P., Paakko P., Solni Y., Kinnula V.L. Expression and regulation of hemeoxygenase 1 in healthy human lung and interstitial lung disorders. Hum. Pathol. 32:(11):2001;1257-1263.